Success Metrics

Clinical Success Rate
80.0%

Based on 4 completed trials

Completion Rate
80%(4/5)
Active Trials
2(25%)
Results Posted
25%(1 trials)
Terminated
1(13%)

Phase Distribution

Ph not_applicable
3
38%
Ph phase_2
3
38%
Ph phase_3
1
13%

Phase Distribution

0

Early Stage

3

Mid Stage

1

Late Stage

Phase Distribution7 total trials
Phase 2Efficacy & side effects
3(42.9%)
Phase 3Large-scale testing
1(14.3%)
N/ANon-phased studies
3(42.9%)

Highest Phase Reached

Phase 3

Trial Status & Enrollment

Completion Rate

66.7%

4 of 6 finished

Non-Completion Rate

33.3%

2 ended early

Currently Active

2

trials recruiting

Total Trials

8

all time

Status Distribution
Active(2)
Completed(4)
Terminated(2)

Detailed Status

Completed4
Recruiting2
Withdrawn1
Terminated1

Development Timeline

Analytics

Development Status

Total Trials
8
Active
2
Success Rate
80.0%
Most Advanced
Phase 3

Trials by Phase

Phase 23 (42.9%)
Phase 31 (14.3%)
N/A3 (42.9%)

Trials by Status

withdrawn113%
completed450%
recruiting225%
terminated113%

Recent Activity

Clinical Trials (8)

Drug Details

Intervention Type
PROCEDURE
Total Trials
8